© 2022 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Special Note: it is always helpful to know where research is, where it is headed,
In order to stay vigilant for a breakthrough and potential for “cross over” to different cancers and sarcomas . . . .and eventually land on the LMS doorstep.
Knowing as much as you can, allows for better information exchange with your oncology team.
FDA Approves Tibsovo Plus Vidaza For Patients With Newly Diagnosed Acute Myeloid Leukemia
Surgery Timing May Have ‘Little Effect’ on Time to Ovarian Cancer Disease Progression
Will My Daughter Be a Triple-Positive Breast Cancer Pioneer?
Trial Will Investigate Drug Duo in Solid Cancers With MAPK Pathway Aberrations